Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.62
-0.08
(-2.96%)
USD |
NASDAQ |
Oct 30, 16:00
2.64
+0.02
(+0.76%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Net Income (Quarterly) : -56.45M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -56.45M |
| March 31, 2026 | -42.11M |
| December 31, 2025 | -38.80M |
| September 30, 2025 | -44.76M |
| June 30, 2025 | -28.44M |
| March 31, 2025 | -22.06M |
| Date | Value |
|---|---|
| December 31, 2024 | -19.69M |
| September 30, 2024 | -17.32M |
| June 30, 2024 | 2.212M |
| March 31, 2024 | 1.100M |
| December 31, 2023 | -0.0417M |
| December 31, 2022 | -0.0035M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Korsana Biosciences, Inc. | -1.755M |
| IRulya Therapeutics, Inc. | -75.49M |
| PepGen Inc. | -17.81M |
| Q32 Bio, Inc. | -8.946M |
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 56.45M |
| EPS Diluted (Quarterly) | -705.20 |
| Enterprise Value | -13.30M |
| Earnings Yield | -47.05K% |
| Normalized Earnings Yield | -47054.49 |